Association Between Psychosocial Risk Factors and Readmissions After Acute Myocardial Infarction: Role of COVID-19 Pandemic
Bansal K, Majmundar V, Muthyala A, Arun Kumar P, Dasari M, Kasireddy T, Yukselen Z, Singh T, Nakhla M, Anugu V, Desai N, Ganatra S, Dani S. Association Between Psychosocial Risk Factors and Readmissions After Acute Myocardial Infarction: Role of COVID-19 Pandemic. Current Problems In Cardiology 2023, 48: 101881. PMID: 37336310, PMCID: PMC10276487, DOI: 10.1016/j.cpcardiol.2023.101881.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionPsychosocial risk factorsRisk factorsCause readmissionMyocardial infarctionMultivariable hierarchical logistic regressionIndex acute myocardial infarctionCause-specific readmissionsCV risk factorsHeart failure readmissionNationwide Readmissions DatabaseWorse cardiovascular outcomesCOVID-19 time periodCOVID-19 pandemicHierarchical logistic regressionIndex admissionCardiovascular outcomesUnplanned readmissionSecondary outcomesPrimary outcomePrimary diagnosisHigh prevalenceReadmissionPatientsLogistic regressionClinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States
Desai N, Sutton M, Xie J, Fine J, Gao W, Owens A, Naidu S. Clinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States. The American Journal Of Cardiology 2023, 192: 16-23. PMID: 36709525, DOI: 10.1016/j.amjcard.2022.12.030.Peer-Reviewed Original ResearchConceptsObstructive hypertrophic cardiomyopathyHypertrophic cardiomyopathyIndex dateCardiovascular eventsIncidence rateSymptomatic obstructive hypertrophic cardiomyopathyAtrial fibrillation/flutterCommon cardiovascular eventMonths continuous eligibilityHealthcare resource utilizationMedicare Supplemental databasesIBM MarketScan CommercialEligible patientsDiagnosis dateMarketScan CommercialClinical outcomesContinuous eligibilityTreatment optionsCumulative riskPatientsResource utilizationPharmacotherapyCardiomyopathyDisease